ABSTRACT
OBJECTIVE: This study examined the hypothesis that ipsilateral upper extremity elevation for muscle-sparing thoracotomy procedures contributes to the postoperative shoulder pain. DESIGN: Prospective observational study. SETTING: Medical center. PARTICIPANTS: ASA physical status 1-2 patients undergoing elective lung surgeries including pneumonectomy, lobectomy, and segmentectomy performed through either the anterolateral approach or video-assisted thoracotomy surgery. INTERVENTIONS: Postoperative observation of ipsilateral shoulder pain. MEASUREMENTS AND MAIN RESULTS: Postoperative examinations of sites of shoulder pain (clavicle, anterior, lateral,or posterior aspect of acromion, posterior neck, supraspinatus, infraspinatus, and these entire areas) with or without trigger points, visual analog scale score of wound pain, and requested counts of analgesics. The number of patients who suffered from postoperative shoulder pain was 37 of 70 (52.9%). Demographic data, anterolateral/VATS ratio, VAS scores, and requested counts of rescue analgesics requirement were similar in the groups of patients with and without postoperative shoulder pain. The segmentectomy caused a significantly higher incidence of postoperative shoulder pain compared with other procedures (p < 0.05). The supra- and infraspinatus were significantly higher areas of painful regions compared to the other sites. The 16 of 37 patients (43.2%) with shoulder pain showed defined trigger points in their painful areas. CONCLUSION: These results supported the hypothesis that myofascial involvement contributed, to some extent, to shoulder pain after muscle-sparing thoracotomy with ipsilateral upper extremity elevation.
Subject(s)
Muscle, Skeletal/physiopathology , Muscular Diseases/etiology , Myofascial Pain Syndromes/complications , Pain, Postoperative/etiology , Shoulder Pain/etiology , Thoracic Surgery, Video-Assisted/adverse effects , Thoracic Surgery, Video-Assisted/methods , Thoracotomy/adverse effects , Thoracotomy/methods , Aged , Anesthesia, General , Endpoint Determination , Female , Humans , Lung/surgery , Male , Middle Aged , Muscular Diseases/physiopathology , Pain Measurement , Patient Positioning , Prospective Studies , Retrospective Studies , Upper ExtremityABSTRACT
We examined the relationships between recall of dreaming during anesthesia and postoperative nausea and vomiting (PONV). We found a relationship between PONV within 24 h and age <50 years, use of postoperative epidural analgesia with morphine, and female gender. We also found a relationship between PONV lasting more than 24 h and dream recall. As serotonin plays an important role for both inducing PONV and dream recall, results of the present study may suggest a possible relationship between dream recall and PONV.
Subject(s)
Analgesia, Epidural/adverse effects , Dreams/physiology , Postoperative Nausea and Vomiting/etiology , Female , Humans , Male , Middle Aged , Morphine/administration & dosageABSTRACT
BACKGROUND: Emergency surgery itself induces high risk for postoperative mortality and morbidities; however, it remains unknown which concomitant pathological conditions of emergency surgeries are causative factors of deteriorating outcomes. This study examined the causal factors of postoperative mortality and morbidity in cases of emergency surgery. METHODS: Patients undergoing emergency surgery from January to December 2007 were enrolled in this retrospective cohort study. Causal relationships were analyzed by stepwise multivariate logistic regression analysis between possible independent factors (sex, age, kind of surgical department, timing of surgery, duration of surgery, blood transfusion, deteriorated consciousness level, shock state, abnormal coagulate state, and history of hypertension, diabetes, ischemic heart disease, chronic obstructive pulmonary disease, renal failure, and anemia) and postoperative mortality or morbidities (failure of removal of tracheal tube after operation, tracheotomy, cerebral infarction, massive hemorrhage, severe hypotension, severe hypoxemia, and severe arrhythmia during or after surgery). RESULTS: Shock, deteriorated consciousness level, chronic obstructive lung disease, and ischemic heart disease were significant risk factors for mortality (OR 14.2, 7.9, 6.4, and 3.8, respectively), and deteriorated consciousness level, blood transfusion, shock, chronic obstructive lung disease, diabetes, cardiovascular surgery, and operation longer than 2 h were significant risk factors for morbidity (OR 19.1, 3.3, 3.0, 2.5, 2.4, 2.4, and 1.8, respectively). CONCLUSION: State of shock, deteriorated consciousness level, chronic obstructive lung disease, ischemic heart disease, hemorrhage requiring blood transfusion, age over 80 years, cardiovascular surgery, surgeries at night, and surgeries of duration more than 2 h cause patients to be strongly susceptible to postoperative mortality or morbidity in emergency surgeries.
Subject(s)
Surgical Procedures, Operative/adverse effects , Surgical Procedures, Operative/mortality , Aged, 80 and over , Emergency Medical Services/methods , Female , Humans , Male , Morbidity , Postoperative Period , Retrospective Studies , Risk FactorsABSTRACT
BACKGROUND: Adenosine triphosphate (ATP)-sensitive K(+) channels contribute to significant regulatory mechanisms related to organ blood flow in both physiological and pathological conditions. High glucose impairs arterial ATP-sensitive K(+) channel activity via superoxide production. However, the effects of anesthetics on this pathological process have not been evaluated in humans. In the present study, we investigated whether pretreatment with the volatile anesthetic isoflurane preserves ATP-sensitive K(+) channel activity in the human artery exposed to oxidative stress caused by high glucose. METHODS: All experiments were performed using human omental arteries without endothelium in the presence of d-glucose (5.5 mmol/L). Some arteries were treated with isoflurane (1.15% or 2.3%) in combination with d- or l-glucose (20 mmol/L) for 60 minutes, and then only isoflurane was discontinued. Relaxation and hyperpolarization of arterial segments in response to an ATP-sensitive K(+) channel opener levcromakalim were evaluated using the isometric force recording or electrophysiological study, respectively. Superoxide production was determined by dihydroethidium fluorescence. Immunohistochemical analysis for a subunit of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p47phox was performed. Data were evaluated using repeated-measures analysis of variance or a factorial analysis of variance as appropriate, followed by Scheffé test. RESULTS: The ATP-sensitive K(+) channel antagonist glibenclamide (10(-6) mol/L) abolished relaxation induced by cumulative addition of levcromakalim (10(-8) to 10(-5) mol/L) in arteries treated with l-glucose (20 mmol/L). Incubation with d-glucose (20 mmol/L) impaired the vasorelaxation induced by levcromakalim. The selective NADPH oxidase NOX2 inhibitor gp91ds-tat (10(-6) mol/L) and pretreatment with isoflurane (1.15% and 2.3%) restored relaxation in response to levcromakalim in arteries treated with d-glucose (20 mmol/L). Isoflurane (2.3%), gp91ds-tat (10(-6) mol/L), and their combination similarly restored hyperpolarization in response to levcromakalim (3 × 10(-6) mol/L) in arteries treated with d-glucose (20 mmol/L). Along with these results, isoflurane (2.3%) reduced superoxide production and the intracellular mobilization of the cytosolic NOX2 subunit p47phox toward smooth muscle cell membrane in arteries treated with d-glucose (20 mmol/L). CONCLUSIONS: We have demonstrated for the first time a beneficial effect from the pretreatment with isoflurane on the isolated human artery. Pretreatment with isoflurane preserves ATP-sensitive K(+) channel activity in the human omental artery exposed to oxidative stress induced by high glucose, whereas the effect seems to be mediated by NADPH oxidase inhibition. Volatile anesthetics may protect human visceral arteries from malfunction caused by oxidative stress.
Subject(s)
Anesthetics, Inhalation/pharmacology , Arteries/drug effects , Glucose/metabolism , Isoflurane/pharmacology , KATP Channels/drug effects , Omentum/blood supply , Oxidative Stress/drug effects , Aged , Arteries/metabolism , Cromakalim/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Female , Humans , Immunohistochemistry , KATP Channels/metabolism , Male , Membrane Potentials , Middle Aged , Myography , NADPH Oxidases/antagonists & inhibitors , NADPH Oxidases/metabolism , Potassium Channel Blockers/pharmacology , Superoxides/metabolism , Time Factors , Vasodilation/drug effects , Vasodilator Agents/pharmacologyABSTRACT
BACKGROUND: We sought to determine the effect of remifentanil on sinus node function and the atrial-His (AH) interval in pediatric patients undergoing radiofrequency catheter ablation. METHODS: Sixty pediatric patients with Wolff-Parkinson-White syndrome were prospectively enrolled in this study. General anesthesia was induced and maintained with a continuous infusion of propofol. We recorded the calculated sinoatrial conduction time (CSACT), corrected sinus node recovery time (CSNRT), and AH interval when the patients were in a stable anesthetic state and compared the values before and during remifentanil administration at a moderate dose (0.2 µg · kg(-1) · min(-1)) or a high dose (0.4 µg · kg(-1) · min(-1)). Data are expressed as mean (95% confidence interval). RESULTS: At the moderate dose, remifentanil prolonged CSNRT (from 177 [117-237] milliseconds to 245 [167-322] milliseconds after administration; P=0.016), but had no effect on either CSACT (P=0.59) or AH interval (P=0.11). However, high-dose remifentanil prolonged both CSNRT (from 201 [144-260] milliseconds to 307 [232-382] milliseconds after administration; P=0.019) and CSACT (from 48 [31-65] milliseconds to 78 [59-96] milliseconds after administration; P=0.038), but had no effect on the AH interval (P=0.058). The interaction in CSNRT between remifentanil administration and its dose was not different (P=0.44). CONCLUSION: Remifentanil may inhibit both intraatrial conduction and sinus node automaticity, but it has no effect on conduction through the atrioventricular node. Dose dependency was not observed within the range of 0.2 to 0.4 µg · kg(-1) · min(-1) of remifentanil.
Subject(s)
Analgesics, Opioid/administration & dosage , Anesthetics, Intravenous/administration & dosage , Catheter Ablation , Periodicity , Piperidines/administration & dosage , Propofol/administration & dosage , Sinoatrial Node/drug effects , Wolff-Parkinson-White Syndrome/surgery , Action Potentials , Age Factors , Bundle of His/drug effects , Bundle of His/physiopathology , Child , Female , Heart Atria/drug effects , Heart Atria/physiopathology , Humans , Infusions, Intravenous , Japan , Male , Prospective Studies , Refractory Period, Electrophysiological , Remifentanil , Sinoatrial Node/physiopathology , Time Factors , Wolff-Parkinson-White Syndrome/physiopathologyABSTRACT
PURPOSE: The effect of volatile anesthetics on the mechanism(s) of vascular contraction in diabetes mellitus (DM) has not been fully understood. The current study was designed to determine the effects of sevoflurane on the norepinephrine (NE)-induced changes in contractile state and intracellular Ca²(+) concentrations ([Ca²(+)](i)) in the spontaneously developing type 2 DM rat. METHODS: The effects of sevoflurane on NE (10â»6M)-induced vasoconstriction and increase in [Ca²(+)](i) in the aortas from Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a type 2 DM model, and from age-matched control Long-Evans Tokushima Otsuka (LETO) rats were investigated using an isometric force transducer and fluorometer with fura-2 as an indicator of [Ca²(+)](i). RESULTS: Norepinephrine-induced increases in tension and [Ca²(+)](i) in OLETF rats were 54.8%, 95% confidence interval (CI) 36.9-72.6% and 58.8%, 95% CI 51.5-66.1%, respectively, and in LETO rats they were 46.4%, 95% CI 39.0-53.7% and 53.8%, 95% CI 46.9-60.7%, respectively, when expressed as the percentage relative to that induced by KCl 30 mM. In LETO rats, sevoflurane at a concentration of 3.4% inhibited the vascular contraction (9.4%, 95% CI 6.3-12.6%; P < 0.001) and the increase in [Ca²(+)](i) (33.3%, 95% CI 27.4-39.2%; P = 0.002). In OLETF rats, however, sevoflurane failed to affect either the NE-induced contraction (43.6%, 95% CI 28.3-58.9%; P = 0.68) or the elevation in [Ca²(+)](i) (60.5%, 95% CI 56.3-64.8%; P = 0.93). CONCLUSION: Sevoflurane at clinically relevant concentrations inhibited the NE-induced increase in [Ca²(+)](i) in the aortic smooth muscle from normal rats but not in that from type 2 DM rats. Thus, a Ca²(+)- signalling pathway resistant to sevoflurane appears to exist in the type 2 DM rat aorta.
Subject(s)
Anesthetics, Inhalation/pharmacology , Calcium/metabolism , Methyl Ethers/pharmacology , Norepinephrine/pharmacology , Animals , Aorta/drug effects , Aorta/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 2/physiopathology , Male , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Sevoflurane , Vasoconstriction/drug effectsABSTRACT
Methemoglobinemia is a fatal complication of local anesthesia. We describe a case report of female neonate who developed severe methemoglobinemia after extraction of neonatal teeth conducted with general anesthesia plus local injection of Citanest-Octapressin(®) (propitocaine of approximately 10 mg/kg). Central cyanosis appeared within an hour after surgery. The percentage of methemoglobin reached up to 43.9%. Not only pediatric dentists but also anesthesiologists generally agree with the idea that local anesthesia provides various benefits in painful procedures in neonates. However, this case may serve as a warning when using Citanest-Octapressin(®), which is still commercially available for neonatal patients.
Subject(s)
Anesthesia, Dental/adverse effects , Anesthetics, Local/adverse effects , Methemoglobinemia/etiology , Postoperative Complications/etiology , Prilocaine/adverse effects , Female , Humans , Infant, Newborn , Tooth ExtractionABSTRACT
BACKGROUND: In some types of pediatric supraventricular tachycardia, reentrant mechanisms are sensitive to enhanced vagal tone. Propofol is a feasible anesthetic for pediatric electrophysiological study and radiofrequency catheter ablation. Although fentanyl and propofol infusions both enhance cardiac vagal tone, it is unclear whether the combination of propofol and fentanyl has a potential to enhance it. In this study, we evaluated the hypothesis that fentanyl combined with propofol could alter cardiac electrophysiological activities in pediatric patients undergoing electrophysiological study and radiofrequency catheter ablation. METHODS: Twenty-seven pediatric patients (9 Wolff-Parkinson-White syndrome, 7 concealed accessory pathway and 11 atrioventricular nodal reentry tachycardia) were enrolled in this study. Anesthesia was induced with propofol 2.0 mg/kg and was maintained with a continuous infusion of propofol at a rate of 100-167 microg x kg(-1) x min(-1). During a stable anesthetic state, the calculated sinoatrial conduction time and corrected sinus node recovery time (CSNRT) were measured before and after fentanyl administration. The fentanyl dose consisted of an initial 2.0 microg/kg IV bolus and subsequent continuous infusion of 0.075 microg x kg(-1) x min(-1). RESULTS: Bispectral Index scores and systemic blood pressure remained unchanged throughout the examinations. Fentanyl administration significantly prolonged CSNRT (P = 0.005) but not calculated sinoatrial conduction time (P = 0.35). CONCLUSION: Since an enhanced cardiac vagal tone is one of the causative factors for prolonged CSNRT, our findings greatly support the hypothesis that fentanyl combined with propofol has a potential to enhance cardiac vagal tone.
Subject(s)
Anesthetics, Combined/adverse effects , Anesthetics, Intravenous/adverse effects , Fentanyl/adverse effects , Propofol/adverse effects , Sick Sinus Syndrome/physiopathology , Tachycardia, Paroxysmal/physiopathology , Tachycardia, Supraventricular/physiopathology , Blood Pressure/drug effects , Catheter Ablation , Child , Electroencephalography/drug effects , Electrophysiology , Female , Heart/innervation , Heart Conduction System/drug effects , Humans , Infusions, Intravenous , Male , Monitoring, Intraoperative , Tachycardia, Atrioventricular Nodal Reentry/complications , Tachycardia, Atrioventricular Nodal Reentry/surgery , Vagus Nerve/physiology , Wolff-Parkinson-White Syndrome/complications , Wolff-Parkinson-White Syndrome/surgeryABSTRACT
The present study was designed to examine roles of the phosphatidylinositol 3-kinase-Akt pathway and reduced nicotinamide-adenine dinucleotide phosphate oxidases in the reduced ATP-sensitive K(+) channel function via superoxide produced by high glucose in the human artery. We evaluated the activity of the phosphatidylinositol 3-kinase-Akt pathway, as well as reduced nicotinamide-adenine dinucleotide phosphate oxidases, the intracellular levels of superoxide and ATP-sensitive K(+) channel function in the human omental artery without endothelium. Levels of the p85-alpha subunit and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits, including p47phox, p22phox, and Rac-1, increased in the membrane fraction from arteries treated with D-glucose (20 mmol/L) accompanied by increased intracellular superoxide production. High glucose simultaneously augmented Akt phosphorylation at Ser 473, as well as Thr 308 in the human vascular smooth muscle cells. A phosphatidylinositol 3-kinase inhibitor LY294002, as well as tiron and apocynin, restored vasorelaxation and hyperpolarization in response to an ATP-sensitive K(+) channel opener levcromakalim. Therefore, it can be concluded that the activation of the phosphatidylinositol 3-kinase-Akt pathway, in combination with the translocation of p47phox, p22phox, and Rac-1, contributes to the superoxide production induced by high glucose, resulting in the impairment of ATP-sensitive K(+) channel function in the human visceral artery.
Subject(s)
Arteries/enzymology , Hyperglycemia/metabolism , KATP Channels/metabolism , NADPH Oxidases/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Antihypertensive Agents/pharmacology , Arteries/cytology , Arteries/drug effects , Chromones/pharmacology , Cromakalim/pharmacology , Enzyme Inhibitors/pharmacology , Glucose/pharmacology , Glyburide/pharmacology , Humans , Hyperglycemia/drug therapy , Hypoglycemic Agents/pharmacology , In Vitro Techniques , Morpholines/pharmacology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/enzymology , Omentum/blood supply , Phosphorylation , Signal Transduction/drug effects , Signal Transduction/physiology , Superoxides/metabolism , rac1 GTP-Binding Protein/metabolismSubject(s)
Anesthesia, Epidural/methods , Anesthesia, General/methods , Paraparesis, Tropical Spastic/physiopathology , Aged , Amides/administration & dosage , Humans , Male , Methyl Ethers/administration & dosage , Ropivacaine , Sevoflurane , Tramadol/administration & dosage , Vecuronium Bromide/administration & dosageSubject(s)
Brain/physiology , Electroencephalography , Tourniquets/adverse effects , Adult , Humans , MaleABSTRACT
BACKGROUND: C-reactive protein is a crucial risk factor for cardiovascular diseases. Previous studies demonstrated that in patients with obstructive sleep apnea syndrome (OSAS), levels of this protein elevate dependently on the degree of upper airway obstruction. However, it has not been determined whether the surgery for OSAS reduces the levels of C-reactive protein by restoring the airway opening. Therefore, we evaluated the effect of uvulopalatopharyngoplasty (UPPP) on levels of serum C-reactive protein in patients with this syndrome. METHODS: Fifteen adult patients with mild to severe OSAS were enrolled in this study. Levels of serum C-reactive protein and sleep parameters including apnea-hypopnea index a month before and 3 months after UPPP were evaluated using peripheral venous blood and polysomnography, respectively. RESULTS: Uvulopalatopharyngoplasty significantly restored sleep parameters, accompanying with decreased levels of C-reactive protein (from 0.21 +/- 0.17 to 0.10 +/- 0.16 mg/dL, P < .05). CONCLUSIONS: In patients with OSAS, UPPP appears to decrease levels of serum C-reactive protein. Surgical therapy may reduce inflammatory response in these patients.
Subject(s)
C-Reactive Protein/metabolism , Otorhinolaryngologic Surgical Procedures , Palate/surgery , Pharynx/surgery , Sleep Apnea, Obstructive/blood , Sleep Apnea, Obstructive/surgery , Uvula/surgery , Adult , Humans , Middle Aged , Severity of Illness Index , Sleep Apnea, Obstructive/physiopathologySubject(s)
Analgesics, Opioid/therapeutic use , Pain, Intractable/drug therapy , Stroke/complications , Tramadol/therapeutic use , Aged , Analgesics, Opioid/administration & dosage , Follow-Up Studies , Humans , Infusions, Intravenous , Male , Pain, Intractable/etiology , Tramadol/administration & dosageABSTRACT
The present study was designed to examine whether in the human artery, synthetic peroxisome proliferator-activated receptor (PPAR)-gamma agonists restore vasorelaxation as well as hyperpolarization via ATP-sensitive K+ channels impaired by the high concentration of D-glucose and whether the restoration may be mediated by the antioxidant capacity of these agents. The isometric force and membrane potential of human omental arteries without endothelium were recorded. The production rate of superoxide was evaluated using a superoxide-generating system with xanthine-xanthine oxidase in the absence of smooth muscle cells. Glibenclamide abolished vasorelaxation and hyperpolarization in response to levcromakalim. Addition of D-glucose (20 mM) but not L-glucose (20 mM) reduced this vasorelaxation and hyperpolarization. Synthetic PPAR-gamma agonists (troglitazone and rosiglitazone) and/or an inhibitor of superoxide generation (4,5-dihydroxy-1,3-benzene-disulfonic acid, Tiron), but not a PPAR-alpha agonist (fenofibrate), restored vasorelaxation and hyperpolarization in response to levcromakalim in arteries treated with D-glucose. Troglitazone and rosiglitazone, but not fenofibrate, decreased the production rate of superoxide without affecting uric acid generation. These findings suggest that synthetic PPAR-gamma agonists recover the function of ATP-sensitive K+ channels reduced by the high concentration of glucose in human vascular smooth muscle cells and that the effect of these agonists may be mediated in part by their antioxidant capacity.
Subject(s)
Adenosine Triphosphate/physiology , Glucose/administration & dosage , PPAR gamma/agonists , Potassium Channels/physiology , Vasodilation/physiology , Aged , Cromakalim/pharmacology , Dose-Response Relationship, Drug , Female , Glucose/physiology , Glucose/toxicity , Humans , Male , Middle Aged , PPAR gamma/physiology , Vascular Diseases/chemically induced , Vascular Diseases/physiopathology , Vasodilation/drug effectsABSTRACT
PURPOSE: Beta-adrenergic receptor antagonists (beta-antagonists) have long been used to control perioperative tachyarrhythmias. The effects of a beta(1)-antagonist, landiolol, on perioperative hemodynamics are unknown. We aimed to determine the appropriate dosage of landiolol for the treatment of hemodynamic changes in response to endotracheal intubation. METHODS: Sixty-four patients without heart disease or hypertension, were assigned to receive saline (group C) or landiolol (0.1 or 0.3 mg.kg(-1); groups L1 and L3). Anesthesia was induced with propofol (2 mg.kg(-1) iv) followed by saline or landiolol iv. After ventilation with facemask using 2% sevoflurane in 100% oxygen for 90 sec, endotracheal intubation was performed. After intubation, anesthesia was maintained using 1% sevoflurane in combination with 50% nitrous oxide. Values of heart rate and mean arterial blood pressure were recorded before induction to five minutes after intubation. RESULTS: In group C, heart rate and mean blood pressure increased simultaneously after tracheal intubation, compared with baseline values. Heart rate values were attenuated immediately before as well as after intubation in group L3, compared with groups C and L1. Heart rate did not increase after tracheal intubation in group L1, compared with baseline. In contrast, mean arterial blood pressure values did not differ among groups. CONCLUSIONS: The newly developed beta(1)-antagonist landiolol (0.1 and 0.3 mg.kg(-1)) may help prevent tachycardia without affecting blood pressure during the induction of anesthesia.
Subject(s)
Adrenergic beta-Antagonists/pharmacology , Blood Pressure/drug effects , Heart Rate/drug effects , Intubation, Intratracheal , Morpholines/pharmacology , Urea/analogs & derivatives , Urea/pharmacology , Adult , Aged , Double-Blind Method , Humans , Middle AgedABSTRACT
OBJECTIVE: The present study was designed to examine in the human omental artery whether high concentrations of D-glucose inhibit the activity of ATP-sensitive K+ channels in the vascular smooth muscle and whether this inhibitory effect is mediated by the production of superoxide. METHODS AND RESULTS: Human omental arteries without endothelium were suspended for isometric force recording. Changes in membrane potentials were recorded and production of superoxide was evaluated. Glibenclamide abolished vasorelaxation and hyperpolarization in response to levcromakalim. D-glucose (10 to 20 mmol/L) but not l-glucose (20 mmol/L) reduced these vasorelaxation and hyperpolarization. Tiron and diphenyleneiodonium, but not catalase, restored vasorelaxation and hyperpolarization in response to levcromakalim in arteries treated with D-glucose. Calphostin C and Gö6976 simultaneously recovered these vasorelaxation and hyperpolarization in arteries treated with D-glucose. Phorbol 12-myristate 13 acetate (PMA) inhibited the vasorelaxation and hyperpolarization, which are recovered by calphostin C as well as Gö6976. D-glucose and PMA, but not l-glucose, significantly increased superoxide production from the arteries, whereas such increased production was reversed by Tiron. CONCLUSIONS: These results suggest that in the human visceral artery, acute hyperglycemia modulates vasodilation mediated by ATP-sensitive K+ channels via the production of superoxide possibly mediated by the activation of protein kinase C.